Esperer Bioresearch pursues nutritional intervention for COVID-19

Clinical nutrition is needed to ensure proteins, vitamins and minerals are provided

Infections due to recent COVID-19 outbreak maintain similar seasonal pattern to those of immunocompetent patients. Clinical manifestations vary significantly depending on type and degree of immunosuppression, from upper to lower respiratory tract infection and prolonged viral shedding.

In fact the time respiratory manifestation comes as symptoms (systemic) such as inflammation of the airways, impaired lung function, airflow obstruction, morbidity and mortality. Patient can be at risk of fragility, because the disease and the lack of oxygen also consumes muscles. Therefore, clinical nutrition is needed to ensure proteins, vitamins and minerals are provided.

The disease also ‘consumes more’ of these and therefore nutrition and professional support on diet is needed. When people with COVID-19 have other chronic diseases like diabetes or heart disease which also come with a specific dietary guidance, nutritional intervention becomes critical and significant.

“We must not forget respiratory infection is the one which has become a deadly reason for COVID 19 infection. Although the respiratory tract is the third-commonest site of infection in the body, it is the commonest site of fatal infections, which often represents the ‘final common pathway’ complicating the many effects of under-nutrition. For example, deaths among the malnourished with CRV like corona are frequently due to pneumonia. The D vitamins have demonstrated protective effect in preventing lung infections in many studies”, says Raktim Chattopadhyay, Founder & CEO, Esperer Bioresearch.

Hence, along with greater research and inventions of Corona prevention/management in medicines, equal encouragement  of nutritional intervention should be persuade as effective prevention from such deadly viral  infections in the field of research and innovation.